Xiang Wang

Title: Xiang Wang: Innovator in Hemoglobin Modulation and Rab Protein Research

Introduction

Xiang Wang is a notable inventor based in South San Francisco, CA. He has made significant contributions to the fields of biochemistry and molecular biology, particularly in the development of methods related to hemoglobin modulation and Rab proteins. With a total of 2 patents, his work has implications for therapeutic advancements.

Latest Patents

Xiang Wang's latest patents include innovative methods for preparing compounds that modulate hemoglobin. The first patent focuses on processes for preparing a compound of formula I, which are essential for developing new therapeutic agents. The second patent involves phospho-Rab antibodies, which are designed to specifically bind to phosphorylated Rab proteins. This patent details monoclonal antibodies that target human Rab10 and Rab8a proteins, recognizing specific epitopes crucial for various biological assays.

Career Highlights

Throughout his career, Xiang Wang has worked with prominent companies in the biotechnology sector. He has been associated with Global Blood Therapeutics, Inc. and Denali Therapeutics Inc., where he has contributed to groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset in the industry.

Collaborations

Xiang Wang has collaborated with several professionals in his field, including Jason C Dugas and Devon Mundal. These collaborations have fostered an environment of innovation and have led to advancements in their respective research areas.

Conclusion

Xiang Wang's contributions to the fields of hemoglobin modulation and Rab protein research highlight his role as an influential inventor. His patents and career achievements reflect a commitment to advancing scientific knowledge and therapeutic solutions.